1. Home
  2. KFRC vs MRVI Comparison

KFRC vs MRVI Comparison

Compare KFRC & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kforce Inc.

KFRC

Kforce Inc.

HOLD

Current Price

$26.72

Market Cap

578.3M

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.51

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFRC
MRVI
Founded
1962
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
578.3M
472.8M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
KFRC
MRVI
Price
$26.72
$3.51
Analyst Decision
Hold
Buy
Analyst Count
2
7
Target Price
$38.50
$4.57
AVG Volume (30 Days)
239.6K
1.1M
Earning Date
05-04-2026
05-26-2026
Dividend Yield
5.97%
N/A
EPS Growth
N/A
14.29
EPS
1.96
N/A
Revenue
$1,329,007,000.00
$185,743,000.00
Revenue This Year
$2.78
N/A
Revenue Next Year
$4.32
$10.00
P/E Ratio
$13.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.49
$1.67
52 Week High
$52.50
$4.11

Technical Indicators

Market Signals
Indicator
KFRC
MRVI
Relative Strength Index (RSI) 32.11 61.26
Support Level $24.49 $3.25
Resistance Level $31.43 $3.65
Average True Range (ATR) 1.69 0.15
MACD -0.65 0.05
Stochastic Oscillator 12.19 71.18

Price Performance

Historical Comparison
KFRC
MRVI

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: